ASO Author Refections: Evaluation of Endoscopic Response After Neoadjuvant Chemotherapy Guides Distribution of Residual Diseases for Esophageal Squamous Cell Carcinoma

Ann Surg Oncol. 2022 Apr;29(4):2681-2682. doi: 10.1245/s10434-021-11020-y. Epub 2021 Nov 11.

Affiliations

¹ Department of Surgery, Keio University School of Medicine, Tokyo, Japan.
² Department of Surgery, Keio University School of Medicine, Tokyo, Japan. hkawakubo@keio.jp.
³ Biostatistics Unit, Clinical and Translational Research Center, Keio University Hospital, Tokyo, Japan.
⁴ Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan.

PMID: 34762213
DOI: 10.1245/s10434-021-11020-y

No abstract available

Publication types

Comment

MeSH terms

Esophageal Neoplasms* / pathology
Esophageal Squamous Cell Carcinoma* / pathology
Esophagectomy
Humans
Neoadjuvant Therapy
Neoplasm, Residual